You are here
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
SBC: Ejenta, Inc. Topic: DHP163001
The objective of project is to develop a solution that allows doctors, nurses, medics and other healthcare providers to interact with the Electronic Health Record (EHR) in a hands-free manner, while keeping hands completely free to work with patients. TodSBIR Phase I 2017 Department of DefenseDefense Health Agency
SBC: Physical Optics Corporation Topic: DHP163002
To address the DHP and USAMRMC need for a system to augment a dynamic 3D scene registration using augmented reality (AR) to provide anatomically accurate registration and overlays to aid in medical training, Physical Optics Corporation (POC) proposes to develop a new Educational Medical Simulation and Training Augmented-Reality (EMSTAR) tool. The tool is based on the unique combination of low-cost ...SBIR Phase I 2017 Department of DefenseDefense Health Agency
SBC: SEACOAST SCIENCE, INC. Topic: DHA17006
The US Centers for Disease Control and Prevention (CDC) estimate that, on average, approximately 15,000 workers each year in the U.S. suffer respiratory diseases caused by toxic agents in the air. As engineered materials become more dominant in construction of homes, offices and industrial buildings, the potential increases for deleterious solvent, plasticizer, and adhesive vapors infiltrating th ...SBIR Phase I 2017 Department of DefenseDefense Health Agency
SBC: TOYON RESEARCH CORPORATION Topic: DHA17006
Toyon Research proposes to develop a Thermal Desorption tube sampling system, capable of meeting the requirements stated in the project solicitation: a programmable interface that allows adjusting sampling system operation in situ; a mechanical design that supports replacing used tubes to support indefinite sampling periods; and an approach for receiving trigger signals from a real-time sensor. Ba ...SBIR Phase I 2017 Department of DefenseDefense Health Agency
SBC: Physical Optics Corporation Topic: DHA17009
To address the DHA need for a new treatment approach for osteochondral defects that is able to conform to a wide range of complex geometries, Physical Optics Corporation (POC) proposes to develop a new Conformable Orthopaedic Repair Approach (CORA). It is based on minimally invasive delivery of a gel that can be stabilized in situ at the defect site. Specifically, the innovation in our approach is ...SBIR Phase I 2017 Department of DefenseDefense Health Agency
SBC: NANOCOMPOSIX, INC. Topic: DHP16006
Combat soldiers are exposed to vast numbers of dangerous chemicals with potentially adverse health outcomes. This SBIR proposal aims to develop a new class of saliva based diagnostic assays that will measure the bodys response to toxic chemical exposure with a panel of clinically validated biomarkers that are indicative of organ injury. The tests will leverage the proven functionality of lateral ...SBIR Phase II 2017 Department of DefenseDefense Health Agency
SBC: Kalyra Pharmaceuticals, Inc. Topic: NonDOD
There has been considerable interest in the development of alternative therapies for pain management that are neither opioid nor non-steroidal anti-inflammatory drugs (NSAIDs). Kalyra Pharmaceuticals has demonstrated that acetaminophen, also known as APAPSBIR Phase II 2017 Department of DefenseDefense Health Agency
SBC: X-Therma Inc. Topic: DHP16012
A key bottleneck to be addressed in regenerative medicine is hypothermic preservation of cells and tissues, which has been shown to extend survival of cell and tissue-based therapies by decreasing ischemic effect. However, preservation technology is aged, toxic and less effective than desired with typical cell survival post-thaw below 50% and unreliable potency. Current technology greatly hinders ...SBIR Phase II 2017 Department of DefenseDefense Health Agency
SBC: Strategic Operations, Inc. Topic: DHP13001
Strategic Operations is noted for its rapid prototyping, manufacturing, distribution, and training capabilities; while Vcom3D is a leader in developing and fielding highly effective game-based learning products. The transition from R&D to manufacturing the Blended VR/Manikin Humeral Head IO Trainer for the Army and other military service use and commercialization to the civilian market will be se ...SBIR Phase II 2017 Department of DefenseDefense Health Agency
SBC: RESUSITECH, INC. Topic: DHP16009
Trauma is the most common cause of death in ages 1-48. Uncontrolled hemorrhage in the torso is the leading cause of preventable death in military combatants and civilian trauma patients with otherwise survivable injuries. The prospects for survival from hemorrhage-induced traumatic cardiac arrest (HiTCA) are dismal with only about a 1% survival rate. Advances in endovascular technologies have led ...SBIR Phase II 2017 Department of DefenseDefense Health Agency